Located in Wales, OpsiRx Pharmaceuticals is developing products to treat serious ocular diseases such as uveitis, glaucoma and age-related macular degeneration (AMD). Such diseases are growing in prevalence and incidence. New products are required to combat the increase of such devastating conditions which, if untreated, lead to sight loss.
Working with world-leading experts in ophthalmology, OpsiRx is developing products that for unmet medical need in ophthalmology through delivery of products with longer duration of action directly to the eye through minimally invasive needles.
Company Details
- Founded
- 2014
- Address
- Oddfellows House, Newport Road,united Kingdom
- Industry
- Biotechnology
- Keywords
- New York.
- HQ
- Cardiff
Opsirx Pharmaceuticals Ltd Questions
Opsirx Pharmaceuticals Ltd's LinkedIn profile is https://uk.linkedin.com/company/opsirx-pharmaceuticals-ltd
Opsirx Pharmaceuticals Ltd's industry is
Biotechnology
Opsirx Pharmaceuticals Ltd's top competitors are
Genesis Pharma,
Winmedica Pharmaceutical,
Ipharma S.a.,
Avis Greece,
Integris Pharma S.a.,
Schepens Eye Research Institute,
Chipita Global S.a.,
Ecofarm Greece,
Frezyderm,
The Glaucoma Foundation.
Opsirx Pharmaceuticals Ltd's categories are Biotechnology
Opsirx Pharmaceuticals Ltd's founding year is 2014
